These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 12354487

  • 1. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V, Banks E, Reeves G.
    Lancet; 2002 Sep 21; 360(9337):942-4. PubMed ID: 12354487
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cancer issues.
    Marsden J, Sturdee D.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb 21; 23(1):87-107. PubMed ID: 19036643
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V, Million Women Study Collaborators.
    Lancet; 2003 Aug 09; 362(9382):419-27. PubMed ID: 12927427
    [Abstract] [Full Text] [Related]

  • 5. Use of HRT and the subsequent risk of cancer.
    Beral V, Banks E, Reeves G, Appleby P.
    J Epidemiol Biostat; 1999 Aug 09; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [Abstract] [Full Text] [Related]

  • 6. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr 09; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
    Fahlén M, Fornander T, Johansson H, Johansson U, Rutqvist LE, Wilking N, von Schoultz E.
    Eur J Cancer; 2013 Jan 09; 49(1):52-9. PubMed ID: 22892060
    [Abstract] [Full Text] [Related]

  • 8. Recent concerns surrounding HRT.
    Armitage M, Nooney J, Evans S.
    Clin Endocrinol (Oxf); 2003 Aug 09; 59(2):145-55. PubMed ID: 12864790
    [Abstract] [Full Text] [Related]

  • 9. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun 09; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 10. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 09; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 11. Hormone replacement therapy and risk of malignancy.
    Diamanti-Kandarakis E.
    Curr Opin Obstet Gynecol; 2004 Feb 09; 16(1):73-8. PubMed ID: 15128011
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep 09; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

  • 14. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
    Grimes DA, Lobo RA.
    Obstet Gynecol; 2002 Dec 09; 100(6):1344-53. PubMed ID: 12468183
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer.
    Ravdin PM.
    Breast Dis; 2002 Dec 09; 30():3-8. PubMed ID: 19850989
    [Abstract] [Full Text] [Related]

  • 18. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ, Taylor R, Wilcken N, Boyages J.
    Eur J Cancer; 2005 Aug 09; 41(12):1775-81. PubMed ID: 16087330
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Estrogen replacement therapy and breast cancer].
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Tidsskr Nor Laegeforen; 2005 Feb 03; 125(3):282-5. PubMed ID: 15702147
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.